Create Health Ventures Launches $21M Digital Health Fund
New VC firm to boost digital health startups with $21M fund, focusing on payer and pharma engagement for better patient ...
- Latest
- Trending
New VC firm to boost digital health startups with $21M fund, focusing on payer and pharma engagement for better patient ...
Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
Roivant reports strong clinical progress, with significant Phase 3 study completions, revenue growth, and financial strength.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.